$MLKMF Cashflow Statement | Understand Stock

$MLKMF

$0.88 -$0.04 (4.69%) Close

$MLKMF Overview Financial Statements SEC Filings Executives News Red Flags Capital Raising Ownership Insider Transactions Congressional Trades

Financial Statements

Income Statement Balance Sheet Cashflow Statement

Consolidated statements of cash flows

In millions of USD, except per-share amounts

	FY2025 12 months to Dec 31, 2025	FY2024 12 months to Dec 31, 2024	FY2023 12 months to Dec 31, 2023	FY2022 12 months to Dec 31, 2022
CASH FLOWS FROM OPERATING ACTIVITIES:
Net loss
Adjustments to reconcile net loss to net cash used in operating activities:
Stock-based compensation
Depreciation and amortization
Non-cash lease expense
Paid-in-kind interest expense
Provision (recovery) for credit losses
Change in fair value of derivative warrant liabilities
Change in fair value on interest rate collar
Change in fair value of contingent consideration liabilities
Change in fair value of embedded derivative
Amortization of debt issuance costs
Amortization and release of related party liability
Loss on extinguishment of debt
Gain on PPP loan forgiveness
Deferred income taxes
Loss on impairment of goodwill
Loss on acquisition
Loss on impairment of right of use assets
Loss on disposal of equipment
Loss on write-off of loan receivable
Changes in operating assets and liabilities:
Accounts receivable
Related party accounts receivable
Inventories
Prepaid expenses
Other current assets and other assets
Accounts payable
Related party accounts payable
Operating lease liabilities
Other current liabilities and other liabilities
Net cash used in operating activities
CASH FLOWS FROM INVESTING ACTIVITIES:
Capital expenditure on intangible assets
Capital expenditure on property and equipment
Advances for note receivable
Proceeds from trust account
Acquisition of Business Combinations, net of cash acquired
Acquisition of Novaestiq
Cash received from interest rate collar premium
Net cash provided by (used in) investing activities
CASH FLOWS FROM FINANCING ACTIVITIES:
Proceeds from PIPE investments
Payment of PIPE transaction costs
Proceeds from FPA investments
Proceeds from term loan, net of discount
Repayment of term loan
Proceeds from revolving credit facility, net of discount
Repayment of revolving credit facility
Proceeds from note payable
Repayment of note payable
Payment of debt issuance costs
Payment of debt termination fees
RSU taxes paid on behalf of employees
Distribution to pay withholding taxes
Payment of dividends
Net cash (used in) provided by financing activities
CHANGE IN CASH, CASH EQUIVALENTS AND RESTRICTED CASH
Effect of foreign exchange rates on cash and cash equivalents
CASH, CASH EQUIVALENTS AND RESTRICTED CASH - Beginning of period
CASH, CASH EQUIVALENTS AND RESTRICTED CASH - End of period
SUPPLEMENTAL CASH FLOW DATA – CASH PAID:
Income taxes
Interest
NON-CASH INVESTING AND FINANCING ACTIVITIES:
Non-cash portion of distribution agreement acquired
Capital expenditures in accounts payable and accruals
Obagi China Distribution to shareholder
Issuance of stock for acquisition
Obagi Merger
Milk Transaction
Total issuance of stock for acquisition
Conversion of promissory note to warrants
Contingent consideration (Equity classified)
Initial measurement of embedded derivatives
Accrued but unpaid debt issuance costs
Deferred tax liability on acquisition
Reconciliation of cash, cash equivalents and restricted cash. The following table provides a reconciliation of cash, cash equivalents and restricted cash reported within the consolidated balance sheets that sum to the total of the same such amounts shown in the consolidated statements of cash flows:
Cash and cash equivalents
Restricted cash

Comments